Inventor
Robert P. Kimberly
Inventor
Birmingham, AL, US
Overview
Patents· 19 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Kprimary
C07KPeptides23%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations21%
G01NInvestigating or analysing materials by determining their chemical or physical properties21%
A61KPreparations for medical, dental or toiletry purposes20%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms9%
Y02ATechnologies for adaptation to climate change5%
A01KAnimal husbandry2%
PatentTitleYear
9,700,618'Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof'20179,528,993'Agents and methods related to screening for resistance to DR5 and reducing resistance to DR5 agonists'20168,715,668'Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor DR5 and uses thereof'20148,476,030'Agents and methods related to reducing resistance to apoptosis-inducing death receptor agonists'20138,329,180'Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof'20128,129,124'Agents and methods related to reducing resistance to apoptosis-inducing death receptor agonists'20128,119,355'Biomarkers for cancer sensitivity and uses thereof'20128,067,001'Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof'20117,981,421'Combinations of antibodies selective for DR5 and other therapeutic agents'20117,790,165'Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof'20107,713,525'Biomarkers for cancer sensitivity and uses thereof'20107,704,502'Combinations of antibodies selective for DR5 and other therapeutic agents'20107,476,383'Antibody selective for DR4 and uses thereof'20097,279,160'Combinations of DR5 antibodies and other therapeutic agents'20077,244,429'Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof'20076,986,987'Genetic polymorphism in the receptor for IgA'20066,664,052'Genetic polymorphism in a complement receptor'20035,985,561'FC receptor polymorphism'19995,830,652'Method for determining predisposition to severe forms of autoimmune disease by determining Fcy receptor allelic patterns'1998Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1998Based in Closter, NJ, US· patent location history
1999–2017Based in Birmingham, AL, US· patent location history
2003–2014Patents assigned to UAB RESEARCH FOUNDATION (15)· patent assignee history
2011–2014Patents assigned to KIMBERLY ROBERT P (6)· patent assignee history
2011–2014Patents assigned to ZHOU TONG (6)· patent assignee history
2011–2014Patents assigned to KOOPMAN WILLIAM J (3)· patent assignee history
2012–2014Patents assigned to ICHIKAWA KIMIHISA (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| UAB RESEARCH FOUNDATION | 15 | 2003–2014 |
| KIMBERLY ROBERT Pself | 6 | 2011–2014 |
| ZHOU TONG | 6 | 2011–2014 |
| KOOPMAN WILLIAM J | 3 | 2011–2014 |
| ICHIKAWA KIMIHISA | 2 | 2012–2014 |
Locations
| Location | Patents | Span |
|---|---|---|
| Birmingham, AL, US | 18 | 1999–2017 |
| Closter, New Jersey, US | 1 | 1998 |